Patients with microvascular angina typically present with chest pain that is similar to that of classic angina. The pain is often described as a pressure or squeezing sensation in the chest, which may radiate to the arms, neck, jaw, or back. It can be triggered by physical exertion, emotional stress, or even occur at rest. Unlike typical angina, the chest pain in microvascular angina may last longer and does not always respond well to nitroglycerin, a common medication used to relieve angina symptoms.

Diagnosing microvascular angina can be challenging because the coronary arteries often appear normal on an angiogram. A comprehensive workup may include a detailed medical history, physical examination, and various tests. These tests can include stress testing, which evaluates the heart's response to physical exertion, and imaging studies like cardiac MRI or PET scans to assess blood flow in the small vessels. In some cases, a coronary flow reserve test may be performed to measure the blood flow in the small vessels.

The treatment of microvascular angina focuses on relieving symptoms and improving quality of life. Medications commonly used include beta-blockers, calcium channel blockers, and nitrates, which help improve blood flow and reduce chest pain. Lifestyle modifications, such as regular exercise, a heart-healthy diet, and stress management, are also important. In some cases, medications that target the small blood vessels, such as ranolazine or ACE inhibitors, may be prescribed.

The prognosis for patients with microvascular angina varies. While the condition can be chronic and affect daily activities, it is generally not associated with the same high risk of heart attack or death as typical coronary artery disease. However, ongoing symptoms can significantly impact quality of life, and patients may require long-term management to control symptoms and prevent complications.

The exact cause of microvascular angina is not fully understood. It is believed to result from dysfunction of the small blood vessels in the heart, which may be due to factors such as endothelial dysfunction (problems with the inner lining of blood vessels), inflammation, or abnormal constriction of the vessels. Risk factors for developing microvascular angina include high blood pressure, high cholesterol, diabetes, and a sedentary lifestyle.

Microvascular angina is more common in women, particularly postmenopausal women, than in men. It is estimated that a significant proportion of patients with angina and normal coronary arteries may actually have microvascular angina. The condition is often underdiagnosed, as it requires specific testing to identify the dysfunction in the small vessels.

The pathophysiology of microvascular angina involves dysfunction of the small coronary vessels, which can lead to inadequate blood flow to the heart muscle. This dysfunction may be due to impaired dilation of the vessels, increased constriction, or both. The resulting reduced blood flow can cause chest pain and other symptoms, even in the absence of significant blockages in the larger coronary arteries.

Preventing microvascular angina involves managing risk factors and adopting a heart-healthy lifestyle. This includes maintaining a balanced diet, engaging in regular physical activity, controlling blood pressure and cholesterol levels, and avoiding smoking. Stress management techniques, such as mindfulness or relaxation exercises, can also be beneficial in reducing the risk of developing symptoms.

Microvascular angina is a condition characterized by chest pain due to dysfunction of the small blood vessels in the heart. It presents similarly to typical angina but involves normal large coronary arteries. Diagnosis requires specific testing, and treatment focuses on symptom relief and lifestyle modifications. While the condition can affect quality of life, it generally does not carry the same risks as traditional coronary artery disease.

If you experience chest pain that is persistent or occurs with exertion, it is important to seek medical evaluation. Microvascular angina is a condition where the small blood vessels in the heart do not function properly, leading to chest pain. It is more common in women and can be managed with medications and lifestyle changes. Understanding your condition and working closely with your healthcare provider can help manage symptoms and improve your quality of life.

1. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med. 2007;356:830–840.
2. Crea F, Camici PG, Bairey Merz CN. Coronary microvascular dysfunction: an update. Eur Heart J. 2014;35(17):1101-1111.
3. Cox ID, Botker HE, Bagger JP, Sonne HS, Kristensen BO, Kaski JC. Elevated endothelin concentrations are associated with reduced coronary vasomotor responses in patients with chest pain and normal coronary arteriograms. J Am Coll Cardiol. 1999;34:455–460.
4. Kanatsuka H, Eastham CL, Marcus ML, Lamping KG. Effects of nitroglycerin on the coronary microcirculation in normal and ischemic myocardium. J Cardiovasc Pharmacol. 1992;19:755–763.
5. Galiuto L, De Caterina AR, Porfidia A. Reversible coronary microvascular dysfunction: a common pathogenetic mechanism in apical ballooning or Taka–Tsubo syndrome. Eur Heart J. 2010;31:1319–1327.
6. Pepine CJ, Anderson RD, Sharaf BL, et al. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the national heart, lung and blood institute WISE (women's ischemia syndrome evaluation) study. J Am Coll Cardiol. 2010;55:2825–2832.
7. Kaski JC. Pathophysiology and management of patients with chest pain and normal coronary arteriograms (cardiac syndrome X). Circulation. 2004;109:568–572.
8. Buchthal SD, den Hollander JA, Bairey-Merz CN. Abnormal myocardial phosphorus – 31 nuclear magnet resonance spectroscopy in women with chest pain but normal coronary angiograms. N Eng J Med. 2000;342:829–835.
9. van 't Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation. 1998;97:2302–2306.
10. Cassar A, Chareonthaitawee P, Rihal CS, et al. Lack of correlation between noninvasive stress tests and invasive coronary vasomotor dysfunction in patients with nonobstructive coronary artery disease. Circ Cardiovasc Interv. 2009;2:237–244.
11. Herrmann J, Kaski JC, Lerman A. Coronary microvascular dysfunction in the clinical setting: from mystery to reality. European Heart Journal. 2012;33(22):2771-2783.
12. Mittal SR. Diagnosis of coronary microvascular dysfunction – Present status. Indian Heart J. 2015;67(6):552-560.